Delivery Order SPE2DB24D2100-SPE2DB25FBFMQ
Award Date 7/29/25
Potential Completion Date 7/30/25
Potential Value $4.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Xifaxan 550 mg tablets (60-count packages) under a firm fixed-price arrangement with a ceiling value of $22,475.14. This non-set-aside, competitively awarded delivery order is scheduled for completion by July 28, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Xifaxan 550 mg tablets in unit dose packaging (60 count) with a ceiling value of $1,625.31. This competitively awarded, firm fixed price delivery order is scheduled for completion by July 24, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count) with a ceiling value of $1,954.87. The award was issued on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,466.25 to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Xifaxan 550 mg tablets in unit dose packaging (60 count). This is a firm fixed-price delivery order with no set-aside designation, executed through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. The...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,065.14 to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count units) under a firm fixed-price contract. The order was competitively awarded without set-aside provisions and is scheduled for completion by July 31, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $7,403.14 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Xifaxan 550 mg tablets (60-count units). This competitively awarded, firm fixed-price contract is not designated as a set-aside and specifies a place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of July 22, 2025. The contract represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply framework with the...
- The Defense Logistics Agency awarded a delivery order valued at $25,366.11 to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. Xifaxan is a non-systemic antibiotic used primarily in the treatment of traveler's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count units) under a firm fixed-price contract with a ceiling value of $71,126.78. The award was made on July 28, 2025, with an ultimate completion date of July 29, 2025. This non-set-aside contract represents a competitive award to the pharmaceutical distributor, with performance to be fulfilled at the company's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp was awarded a delivery order on July 30, 2025, for the supply of Xifaxan 550 mg tablets (60-count units) with a ceiling value of $77,218.07. This is a firm fixed price, non-competitive delivery order to be completed by July 31, 2025. The contract is executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Xifaxan 550 mg with a ceiling value of $5,936.37. This competitively awarded, firm fixed-price delivery order was issued on July 25, 2025, with an ultimate completion date of July 28, 2025. The contract represents a pharmaceutical supply fulfillment supporting federal medical procurement needs, with performance occurring at the contractor's corporate office location in Conshohocken,...